Abstract Fri092: Selenoprotein S – New binding partner and potential regulator of Sarcoendoplasmic Reticulum Calcium ATPase pump
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Sarcoendoplasmic Reticulum Calcium ATPase (SERCA) regulates cellular calcium homeostasis by transporting Ca2+ from the cytosol back to the sarcoplasmic reticulum (SR) after muscle contraction. Its dysfunction is linked to heart failure. A class of small proteins, regulins, modulates SERCA activity and is considered a therapeutic target for heart disease. Selenoprotein S (selenos) is an ER-residing transmembrane protein with selenocysteine at its C-terminus. It plays a role in ER stress and oxidative stress responses. Selenos has been implicated in calcium flux regulation in some cell types, and its deletion in mice impairs fast-twitch muscle contraction. Additionally, single nucleotide polymorphisms within proximity of SELENOS gene are associated with cardiovascular diseases, prompting further investigation into its role in Ca2+ homeostasis. We first observed a connection between selenos and SERCA2 through a proteomics study in HEK293 cells, where SERCA2 was enriched among selenos-binding partners. Sequence analysis revealed that selenos shares a SERCA recognition motif with known regulins like DWORF and myoregulin and contains a leucine-zipper-like hydrophobic region similar to other regulins such as sarcolipin, phospholamban, and endoregulin. To confirm this interaction, we performed co-immunoprecipitation (co-IP) assays, demonstrating reciprocal binding between selenos and SERCA2. Since selenos is an oxidoreductase, it may influence SERCA function.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Abstract Fri092: Selenoprotein S – New binding partner and potential regulator of Sarcoendoplasmic Reticulum Calcium ATPase pump
- Date Crossref
- 01/08/2025
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.